Scientific Research to Benefit from More Open Innovation

Scientific Research to Benefit from More Open Innovation

By • on October 16, 2014

The IdeaConnection website reported that open innovation is giving science a big boost with the announcement of a challenge fund to advance bioelectronic medicine research and the launch of an open innovation stem cell technology center. To foster collaborative research to develop bioelectronic medicines, GlaxoSmithKline  has created a $5 million innovation

Comments Off on Scientific Research to Benefit from More Open InnovationRead this story »

More Articles

How Open Innovation Can Unlock the Door to Success

How Open Innovation Can Unlock the Door to Success

By • on August 1, 2014

The Yorkshire Post reported that Leeds University Business School recently ran a major research project which brought together academics and businesses from across Europe to look at open innovation. The study saw industrial giants including Bayer MaterialScience, Deutsche Telekom, Siemens, Intel and

Comments Off on How Open Innovation Can Unlock the Door to SuccessRead this story »

Open innovation and Bioscience

Open innovation and Bioscience

By • on April 30, 2014

A blog on the BBSRC website noted two key concepts that are essential to developing a true open innovation environment. The first is proactive management of intellectual property (IP). Many people confuse open access with open innovation – open access is one model of open innovation where IP is

Comments Off on Open innovation and BioscienceRead this story »

Driving Science through Open Innovation

Driving Science through Open Innovation

By • on November 7, 2013

The Information Daily website notes that providing tools and information for academics in the public domain can lead to faster publication  and drug creation, benefiting the whole scientific community, according to Malcolm Skingle of GlaxoSmithKline. In the article Skingle discusses the opportunities

Comments Off on Driving Science through Open InnovationRead this story »

GlaxoSmithKline: Funding Open Innovation

GlaxoSmithKline: Funding Open Innovation

By • on May 3, 2013

The 4-Traders website reported that GlaxoSmithKline (GSK) has announced a funding injection of up to £5m from the Wellcome Trust to support its open approach to discovering and developing urgently needed new treatments for diseases of the developing world. The funding will move early-stage research

Comments Off on GlaxoSmithKline: Funding Open InnovationRead this story »

Opening Industry-Academic Partnerships

Opening Industry-Academic Partnerships

By • on April 17, 2013

Science magazine posted an article by Chris Tachibana which noted that research and development today is about networking, sharing, and partnering. Collaborations between industry and academia are promoted by open innovation programs, which have become a near-universal model for R&D. Pharmaceutical

Comments Off on Opening Industry-Academic PartnershipsRead this story »

Evotec expands open innovation push with Yale

Evotec expands open innovation push with Yale

By • on January 11, 2013

The  Pmlive website announced that Germany’s Evotec has entered into a strategic partnership with Yale University as it continues to adopt an open innovation approach to drug discovery. The latest agreement will see Evotec join forces with Yale  on discovery science for a number of diseases with

Comments Off on Evotec expands open innovation push with YaleRead this story »

Open Innovation in Pharma

Open Innovation in Pharma

By • on December 6, 2012

The Genetic Engineering and Biotechnological News website posted an article which notes that as many big pharmas are maturing they have become more akin to manufacturing organizations with less internal innovation. This is where accessing science from academic centers of excellence and SMEs can help; 

Comments Off on Open Innovation in PharmaRead this story »

Will Pharma Embrace Open Innovation?

Will Pharma Embrace Open Innovation?

By • on October 26, 2012

The PharmTech website notes that recent years of low approvals of new blockbuster products have given rise to the perception that pharmaceutical drug development, in its current format, no longer works. Recent late-stage failures of clinical trials have also served to emphasize the risky nature of

Comments Off on Will Pharma Embrace Open Innovation?Read this story »

GSK to Open Clinical Data Vaults

GSK to Open Clinical Data Vaults

By • on October 25, 2012

The FierceBiotechIT website reports that GlaxoSmithKline has committed to provide researchers with unmatched access to patient-level data from its clinical trials–including studies that failed. The move is among several steps the London-based drug giant announced today to promote open innovation

Comments Off on GSK to Open Clinical Data VaultsRead this story »

Purchase viagra online and purchase it from the good to cope with dependable and trustworthy pharmacy. Don't believe of the recommendation by a mantra but instead as suggestion that is useful since that might be really a correct move to make to think about. It's not just about general ease of doing all of your buying resting before your Computer, or around no prerequisite to depart your home or stand-in point, but additionally concerning the choices you might have barely considered overall. Visit the drugstore you might have handled earlier in the event that you know the thing you need precisely. Examine the options what, why and just how if, nevertheless, you will find neither particular needs or a drugstore to go to.